Year: 2026

Choosing a pharmaceutical API supplier is a quality and business decision, not just a price comparison. A weak supplier can cause failed batches, delayed registrations and supply gaps, while a strong one becomes a long-term partner. A structured evaluation, also called supplier qualification, helps you decide who to trust and how closely to monitor them. This guide gives a step-by-step process to evaluate a pharmaceutical API supplier, with a scoring table, audit tips and ongoing monitoring advice. Key Takeaways Use a risk-based, step-by-step process: define needs, screen, review documents, test samples, audit if needed, agree quality terms and monitor. Match the effort to the risk. Critical or potent APIs need deeper checks than low-risk materials. Evaluate quality systems, not just certificates. Qualification is not one-off. Monitor performance and requalify periodically.   Step 1: Define Your Requirements Before you contact suppliers, write down what you need: API name, grade and pharmacopoeia specification, including impurity and physical requirements quantity, batch size and delivery schedule target markets and regulatory documents required packaging and shipping needs risk level of the product, for example potent or oncology APIs. See HPAPI manufacturing Step 2: Build a Shortlist Use industry directories, trade fairs, referrals and your own market knowledge to identify candidates. Confirm early that each one is actually a manufacturer or clearly states which products it makes and which it sources. See how to choose a reliable API manufacturer in India. Step 3: Send a Supplier Questionnaire Ask about: company details, site address and ownership licences and GMP certification quality system, change control, deviations and data integrity raw material and starting material sourcing and backup suppliers inspection history and complaints handling capacity, lead times and MOQ experience with your regulator or market Step 4: Review the Documents Collect and check the documents. See the full list in documents to request from an API supplier, plus what a CoA is and what a DMF is. Make sure names, addresses, product details and dates are consistent. Step 5: Test Samples Test a sample against your specification, including identity, assay, impurities and any physical properties that matter for your formulation. Compare your results with the supplier’s CoA. Differences should be investigated, not ignored. Step 6: Audit the Supplier For critical products, audit the site, either on site or remotely. Look at: facility condition, flow and cleanliness quality unit independence and authority documentation, batch records and data integrity practices laboratory equipment and testing practices warehouse and material control change control and deviation handling containment and cross-contamination control for potent materials See also GMP in pharmaceutical manufacturing. For lower-risk products, a questionnaire, document review and sample testing may be enough, depending on your quality system. Step 7: Agree a Quality Agreement Put responsibilities in writing: specifications, change notification, audit rights, complaint handling, recalls, documentation, and which site is the approved manufacturing site. Step 8: Start with a Trial Order Place a smaller initial order if possible, review the first batches carefully, and check how the supplier handles questions or issues. Step 9: Monitor and Requalify track on-time delivery, batch results, complaints and deviations review certificates and licences as they expire require notification of changes to process, site or sourcing re-audit or requalify at defined intervals, based on risk Red Flags vague or evasive answers to basic questions refusal of audits or sample testing unclear manufacturing site or conflicting documents prices far below the market with no explanation poor responsiveness before the order, which usually gets worse after Risk-Based Approach Not every supplier needs the same level of checking. Consider the product risk (such as potency or sterility), how critical the material is, the supplier’s history and how easy it is to substitute. Higher risk means deeper checks. Working with Salvavidas Pharma Salvavidas Pharma is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, India, with APIs and finished dosage forms including oncology and anti-HIV/ARV products. See our API products and manufacturing facility. Frequently Asked Questions What is supplier qualification?It is the process of evaluating a supplier to confirm that it can consistently meet your quality, regulatory and supply requirements. Do I need to audit every API supplier?Not necessarily. Audits are usually prioritised for critical, high-risk or high-volume materials, and lower-risk suppliers may be qualified through documents and testing. How long does supplier qualification take?It varies from a few weeks to several months depending on risk, document availability, sample testing and audit scheduling. How often should suppliers be requalified?At intervals set by your quality system and the risk level, and whenever there are significant changes or problems. Want to start supplier qualification with us? Contact our export team. Sources ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients, European Medicines Agency

API process development is the work of turning a chemical reaction that works in a small flask into a safe, reliable, repeatable manufacturing process. Pharmaceutical R&D is what makes that transition possible. Without it, a promising molecule can fail at scale because of poor yield, difficult impurities, safety problems or inconsistent quality. This guide explains the stages of API process development, the role of R&D teams, and what buyers and partners should expect from a supplier with real development capability. Key Takeaways Process development turns a laboratory synthesis into a scalable, controlled manufacturing process. R&D covers route selection, optimisation, impurity understanding, analytical methods, scale-up and technology transfer. A good process is safe, reproducible, cost-effective and produces few difficult impurities. Strong documentation allows the process to be transferred and supports regulatory filings. What Is API Process Development? API process development is the stage between discovering or selecting a molecule and manufacturing it commercially. It defines the synthetic route, the conditions, the materials and the controls needed to make the API consistently at the required purity and scale. See how production works in the API manufacturing process. Stages of API Process Development 1. Route scouting and selection Chemists evaluate possible routes to the target molecule and compare them on safety, number of steps, availability and cost of materials, yield, and the impurities they create. Often the best route in a research paper is not the best route for manufacturing. 2. Laboratory optimisation The chosen route is refined by adjusting temperature, solvents, reagents, times and workup. Structured experiments, often called design of experiments (DoE), help find robust operating ranges instead of a single fragile set of conditions. 3. Impurity profiling and control Teams identify and study impurities, understand where they come from and decide how to control them. Regulators expect control of related substances, residual solvents, elemental impurities and mutagenic impurities, in line with ICH guidelines. 4. Analytical method development Validated methods are needed to measure assay, impurities and other quality attributes. Good methods are developed alongside the process. 5. Physical form and particle properties For many APIs, the crystal form (polymorph), particle size and bulk properties affect how the finished product performs, so crystallisation and drying are carefully developed. 6. Safety and environmental assessment Reactions are reviewed for thermal hazards, reagent risks, waste and solvent use before they are scaled. 7. Scale-up The process moves from lab scale to kilo-lab, pilot and finally commercial scale. Heat transfer, mixing and filtration behave differently in larger equipment, so conditions often need adjustment. 8. Technology transfer and validation The process and its documentation are transferred to the manufacturing site, and validation shows that it consistently produces material meeting specifications. Quality by Design Thinking Modern development often follows quality by design principles, which means understanding how process parameters affect quality so that the process can be controlled, not just tested at the end. ICH guidance on pharmaceutical development and on drug substance development and manufacture describes this approach. What Good R&D Delivers a documented process with defined parameters and ranges validated analytical methods an impurity profile and control strategy data on stability and physical properties scale-up and tech transfer documents information to support regulatory filings such as a DMF Why It Matters to Buyers A supplier with real process knowledge is more likely to deliver consistent batches, manage changes properly, troubleshoot problems and support new products. When evaluating a supplier, ask about their development capability and how they manage process changes. See how to evaluate a pharmaceutical API supplier. R&D and Custom Synthesis at Salvavidas Pharma Salvavidas Pharma is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, India. Learn more about our pharmaceutical R&D and custom synthesis services and pharmaceutical intermediates. Frequently Asked Questions What is the difference between R&D and process development? R&D is the broader research activity. Process development is the part that creates a scalable manufacturing process for a chosen molecule. How long does API process development take? It depends on the molecule, complexity and scale. Simple processes may take months, and complex ones longer. Ask for a timeline in the project proposal. Why do processes need to be optimised before scale-up? Because conditions that work in small flasks may give lower yield, new impurities or safety issues in large reactors. What is technology transfer? It is the formal transfer of a developed process and its documentation to the site that will manufacture it at scale. Need development or custom synthesis support? Contact our team. Sources ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients, European Medicines Agency

The difference between an API and a finished formulation is simple: the API is the active ingredient, and the finished dosage form (FDF) is the final medicine that patients take. But the two differ in how they are made, regulated, sold and used, and buyers who confuse them can end up sourcing the wrong product. This guide explains API vs finished formulation, compares them side by side, and helps you decide which one your business needs. Key Takeaways The API is the active substance. The finished dosage form is the complete medicine, such as a tablet, capsule or injection, made from the API plus excipients. APIs are sold to manufacturers. Finished dosage forms are sold to distributors, hospitals, pharmacies and tenders. They follow different manufacturing processes, quality tests and regulatory routes. Many companies work in one or both, and some buyers choose third-party manufacturing to get finished products without their own plant.   What Is an API? An active pharmaceutical ingredient is the component of a medicine that produces its therapeutic effect. It is usually a powder or crystalline material. Learn more in what an active pharmaceutical ingredient is. What Is a Finished Dosage Form? A finished dosage form is the final product in a form that can be given to a patient, with the correct dose, packaging and labelling. Examples include tablets, capsules, syrups, creams, injections and infusions. It contains the API together with excipients that help with stability, delivery and taste. Side-by-Side Comparison Feature API Finished dosage form (FDF) What it is The active ingredient The final medicine in a usable form Examples Paracetamol powder Paracetamol tablet or infusion Made by Chemical synthesis, fermentation or extraction Formulation: mixing, granulation, compression, filling and packing Other ingredients None, or only minimal Excipients, solvents or packaging components Typical quality tests Assay, impurities, residual solvents, water content Assay, dissolution or content, uniformity, sterility for injectables, stability Manufacturing standard GMP for APIs (ICH Q7) GMP for finished pharmaceutical products Typical buyers Formulators and other manufacturers Distributors, hospitals, pharmacies and tenders Regulatory route DMF, ASMF or CEP, and API data in the product file Marketing authorisation or registration of the finished product Shipping and storage Packs, cartons and shippers Bulk containers, often in drums How They Are Made Differently APIs are produced through chemistry and purification, as described in the API manufacturing process. Finished dosage forms are made by combining the API with excipients and processing it into the final form, for example compressing tablets or filling vials, under controlled conditions. How They Are Regulated Differently Both need GMP, but the guidelines and files differ. APIs follow ICH Q7 and may have a DMF, ASMF or CEP. See what a DMF is. Finished products need to be registered or authorised in each country, with data on the formulation, manufacturing, stability and the API source. See GMP in pharmaceutical manufacturing. Which Do You Need? You make your own medicines: you need APIs, and you also need qualified excipient and packaging suppliers. You want to sell branded or generic medicines without a plant: you need finished products, through third-party or contract manufacturing. See our guide to third-party pharma manufacturing. You supply tenders and hospitals: you usually need finished products with the right registrations. You develop or test formulations: you need APIs and technical documents. Business Models in Practice Some companies make only APIs, some make only finished products, and some do both. A company that does both can offer more control over the supply chain. Ask each supplier which products it manufactures and which it sources. What to Check When Buying Either manufacturer identity and GMP certificate specifications and the Certificate of Analysis stability data and shelf life regulatory documents for your market packaging, labelling and shipping conditions See how to evaluate a pharmaceutical API supplier. APIs and Finished Dosage Forms at Salvavidas Pharma Salvavidas Pharma is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, India. We work across both APIs and finished dosage forms, including generics, oncology and anti-HIV/ARV products. Explore our API products and finished formulations. Regulatory Support at Salvavidas Pharma Salvavidas Pharma is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, India. See our regulatory services. Frequently Asked Questions Is an API the same as a drug?Not exactly. The API is the active substance. The drug or medicine is the finished product that contains it. Can I sell APIs directly to patients?No. APIs are not meant for direct use. They are processed into finished medicines by licensed manufacturers. Which is more profitable, API or FDF?It depends on the market, product, competition and scale. APIs are often more commodity-driven, while finished products need registrations and marketing. Can one company make both?Yes, many companies do, and that is called being backward integrated. Looking for APIs or finished products? Contact our export team.